AUSTIN, TEXAS, March 9, 2016 -- MAP Health Management, an innovative company whose mission is to improve outcomes for individuals battling the disease of addiction, is closely tracking post treatment outcomes of people struggling with opioid abuse, which is destroying lives across our nation. The following MAP spokespeople below are available for interviews and can speak about rates of admission, length of treatment required, types of treatment found most effective, and demographics most likely to relapse.
*Jacob Levenson, Chief Executive Officer: Under Jacob's leadership, MAP is pioneering data-driven strategies in all 50 states, providing telehealth services and tracking the progress of thousands of addicts in recovery nationwide following in-patient treatment. The results are powerful, giving those struggling with addiction comprehensive treatment throughout the critical first year of their recovery and providing valuable outcomes data to vastly improve treatment. In 2015, Jacob launched the MAP Recovery Network, which is comprised of addiction treatment providers who are dedicated to using telehealth and outcomes data to drive addiction treatment. The network gives those seeking treatment the ability to make informed decisions based upon the success rates of recovery programs and health insurers the ability to reimburse the most effective treatment providers.
*Dr. Kerby Stewart, M.D., Clinical Director: Dr. Stewart provides clinical oversight to the MAP Recovery Support division, a post-discharge telephone and videoconference-based recovery support system for adults, adolescents and their families who seek to achieve long-term recovery from chemical dependency. Dr. Stewart was the Clinical Coordinator for Substance Abuse Programs at the Texas Department of State Health Services, where he focused on the implementation of evidence-based practices in both substance abuse treatment and long-term recovery support services. He has practiced Psychiatry and Emergency Medicine. In addition, he was an Associate Professor of Medicine at the Austin Academy of Integrative and Oriental Medicine. Dr. Stewart has been associated with the field of Addiction Medicine since working as a volunteer in 1981 at the Haight-Ashbury Free Clinic in San Francisco.
To arrange an interview, please contact:
Marichelli Hughes
SevenTwenty Strategies
202-715-3906
[email protected]
MAP Health Management, LLC is the industry leader in providing comprehensive outcome data, aftercare programs and revenue cycle management to addiction treatment providers across the country. Nationally recognized treatment facilities trust MAP to help them navigate and thrive in the new healthcare paradigm. Since 2011, MAP's dedicated team of research analysts, recovery specialists, technology professionals and billing experts have worked to improve patient outcomes, empower treatment providers with data, reduce costs and drive facility revenue. For more information, visit www.ThisIsMAP.com.
CONTACT: Marichelli Hughes
202-715-3906
[email protected]


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



